| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |